K. Marien

64 SAFETY OF THE HCV PROTEASE INHIBITOR TMC435350 IN HEALTHY VOLUNTEERS AND SAFETY AND ACTIVITY IN CHRONIC HEPATITIS C INFECTED INDIVIDUALS: A PHASE I STUDY

P. V. Remoortere, A. Vliet, F. Broeckaert, 2008 .

PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials

B. Malcolm, R. Verloes, J. Vingerhoets, 2018, Antiviral Research.

Safety and Pharmacokinetics of the HIV-1 Protease Inhibitor TMC310911 Coadministered With Ritonavir in Healthy Participants: Results From 2 Phase 1 Studies

P. Meyvisch, R. Verloes, R. Hoetelmans, 2014, Journal of acquired immune deficiency syndromes.

1188 COMBINATION THERAPY OF TMC647055 WITH SIMEPREVIR (TMC435) IN CHRONIC HEPATITIS C PATIENTS

P. V. Remoortere, S. Bourgeois, H. Reesink, 2013 .